ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

November 26, 2010

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994

Should Be Cut First, DCT Board Says

December 4, 1981

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992